337 Although all cell types responded to this inhibitor in vitro and showed promising therapeutic effects in vivo, 337 phase I clinical trials for treating advanced solid tumors ultimately failed due to cardiovascular toxicity and wide variability in patient responses
The authors of this week's study used data culled from the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance project to determine that during a two-year period from 2022 to 2023, an estimated 24,499 emergency room visits related to semaglutides were recorded
Low blood pressure (hypotension) is rarely a concern with semaglutide alone, but when combined with aggressive blood pressure medications, some individuals experience dizziness, lightheadedness, or fatigue
The agencynot the committeewill decide what happens next
American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults